GSK Antikörper
Empty Table Header | Produkt | Katnr. | Isotyp | Epitop | Anwendungen | Species | Referenzen | Bewertung |
---|---|---|---|---|---|---|---|---|
GSK-3α Antikörper (H-12) | sc-5264 | mouse IgG1 κ | 464-483 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 14 | ||
GSK-3α Antikörper (10C1) | sc-81463 | mouse IgG1 | (h) | WB, IP | m, r, h and canine | 1 | ||
GSK-3α Antikörper (B-8) | sc-166116 | mouse IgG2a κ | 408-483 (h) | WB, IP, IF, ELISA | m, r, h | 1 | ||
GSK-3α Antikörper (9D5G1) | sc-81166 | mouse IgG1 κ | 84-150 (h) | WB, IP | m, r, h | neu | ||
GSK3 alpha/beta Antikörper (0011-A) | sc-7291 | mouse IgG2a κ | FL (Xenopus laevis) | WB, IP, IF, IHC(P), FCM | m, r, h, canine and Xenopus | 275 | ||
GSK3 alpha/beta Antikörper (1H8) | sc-56913 | mouse IgG2a κ | (Xenopus laevis) | WB, IP | m, r, h and Xenopus laevis | 21 | ||
GSK3 beta Antikörper (E-11) | sc-377213 | mouse IgG1 κ | 345-420 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 66 | ||
GSK3 beta Antikörper (11B9) | sc-81462 | mouse IgG1 | N-Terminal (h) | WB, IP | m, r, h | 82 | ||
GSK3 beta Antikörper (1F7) | sc-53931 | mouse IgG1 | 341-420 (h) | WB, IP | m, r, h | 32 | ||
GSK3 beta Antikörper (1V001) | sc-71186 | mouse IgG2a | (Xenopus laevis) | WB, IP | h, r | 18 | ||
GSK3 beta Antikörper (2Q274) | sc-71188 | mouse IgG2a | (Xenopus laevis) | WB, IP | h, r | 1 |
Phospho-Spezifische GSK Antikörper
Empty Table Header | Produkt | Katnr. | Isotyp | Epitop | Anwendungen | Species | Referenzen | Bewertung |
---|---|---|---|---|---|---|---|---|
p-GSK-3α Antikörper (9B8) | sc-81497 | mouse IgG1 | Ser 21 (h) | WB, IP, IF | m, r, h and canine | 3 | ||
p-GSK-3α Antikörper (E-2) | sc-365483 | mouse IgM κ | Ser 21 (h) | WB, IP, IF, ELISA | m, r, h | 1 | ||
p-GSK3 alpha/beta Antikörper (6D3) | sc-81496 | mouse IgG1 | Tyr 279 (h) | WB, IP | m, r, h | 27 | ||
p-GSK3 beta Antikörper (F-2) | sc-373800 | mouse IgG1 κ | Ser 9 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 99 | ||
p-GSK3 beta Antikörper (3A8) | sc-81495 | mouse IgG1 | Ser 9 (h) | WB, IP | m, r, h and canine | 15 | ||
p-GSK3 beta Antikörper (2D3) | sc-81494 | mouse IgG1 | Ser 9 (h) | WB, IP | m, r, h | 11 |
GSK CRISPR Knockout, HDR and Double Nickase Plasmids
Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
---|---|---|---|---|---|---|---|
GSK-3α CRISPR/Cas9 KO Plasmid (h) | sc-400518 | h | Gene Knockout | GFP | 1 | ||
GSK-3α HDR Plasmid (h) | sc-400518-HDR | h | Homology Directed Repair | Puromycin | 1 | ||
GSK-3α Double Nickase Plasmid (h) | sc-400518-NIC | h | Gene Knockout | Puromycin | 1 | ||
GSK-3α Double Nickase Plasmid (h2) | sc-400518-NIC-2 | h | Gene Knockout | Puromycin | 1 | ||
GSK-3α CRISPR/Cas9 KO Plasmid (m) | sc-436875 | m | Gene Knockout | GFP | 0 | ||
GSK-3α HDR Plasmid (m) | sc-436875-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
GSK-3α Double Nickase Plasmid (m) | sc-436875-NIC | m | Gene Knockout | Puromycin | 0 | ||
GSK-3α Double Nickase Plasmid (m2) | sc-436875-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
GSK3 beta CRISPR/Cas9 KO Plasmid (h2) | sc-400090-KO-2 | h | Gene Knockout | GFP | 1 | ||
GSK3 beta HDR Plasmid (h2) | sc-400090-HDR-2 | h | Homology Directed Repair | Puromycin | 1 | ||
GSK3 beta Double Nickase Plasmid (h) | sc-400090-NIC | h | Gene Knockout | Puromycin | 1 | ||
GSK3 beta Double Nickase Plasmid (h2) | sc-400090-NIC-2 | h | Gene Knockout | Puromycin | 1 | ||
GSK3 beta CRISPR/Cas9 KO Plasmid (m) | sc-425249 | m | Gene Knockout | GFP | 2 | ||
GSK3 beta HDR Plasmid (m) | sc-425249-HDR | m | Homology Directed Repair | Puromycin | 2 | ||
GSK3 beta Double Nickase Plasmid (m) | sc-425249-NIC | m | Gene Knockout | Puromycin | 2 | ||
GSK3 beta Double Nickase Plasmid (m2) | sc-425249-NIC-2 | m | Gene Knockout | Puromycin | 2 |
GSK CRISPR Activation Products
Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
---|---|---|---|---|---|---|---|
GSK-3α CRISPR Activation Plasmid (h) | sc-400518-ACT | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
GSK-3α CRISPR Activation Plasmid (h2) | sc-400518-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
GSK-3α Lentiviral Activation Particles (h) | sc-400518-LAC | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
GSK-3α Lentiviral Activation Particles (h2) | sc-400518-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
GSK-3α CRISPR Activation Plasmid (m) | sc-436875-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
GSK-3α CRISPR Activation Plasmid (m2) | sc-436875-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
GSK-3α Lentiviral Activation Particles (m) | sc-436875-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
GSK-3α Lentiviral Activation Particles (m2) | sc-436875-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
GSK3 beta CRISPR Activation Plasmid (h) | sc-400090-ACT | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
GSK3 beta CRISPR Activation Plasmid (h2) | sc-400090-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
GSK3 beta Lentiviral Activation Particles (h) | sc-400090-LAC | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
GSK3 beta Lentiviral Activation Particles (h2) | sc-400090-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
GSK3 beta CRISPR Activation Plasmid (m) | sc-425249-ACT | m | Gene Activation | Puro, Blast, Hygro | 2 | ||
GSK3 beta CRISPR Activation Plasmid (m2) | sc-425249-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 2 | ||
GSK3 beta Lentiviral Activation Particles (m) | sc-425249-LAC | m | Gene Activation | Puro, Blast, Hygro | 2 | ||
GSK3 beta Lentiviral Activation Particles (m2) | sc-425249-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 2 |
GSK siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
---|---|---|---|---|---|---|---|
GSK-3α siRNA (h) | sc-29339 | h | Gene Silencing | N/A | 8 | ||
GSK-3α shRNA Plasmid (h) | sc-29339-SH | h | Gene Silencing | Puromycin | 8 | ||
GSK-3α shRNA (h) Lentivirale Partikel | sc-29339-V | h | Gene Silencing | Puromycin | 8 | ||
GSK-3α siRNA (m) | sc-35526 | m | Gene Silencing | N/A | 0 | ||
GSK-3α siRNA (m2) | sc-270018 | m | Gene Silencing | N/A | 0 | ||
GSK-3α shRNA Plasmid (m) | sc-35526-SH | m | Gene Silencing | Puromycin | 0 | ||
GSK-3α shRNA (m) Lentivirale Partikel | sc-35526-V | m | Gene Silencing | Puromycin | 0 | ||
GSK-3α siRNA (r) | sc-270583 | r | Gene Silencing | 0 | |||
GSK-3α shRNA Plasmid (r) | sc-270583-SH | r | Gene Silencing | 0 | |||
GSK-3α shRNA (r) Lentivirale Partikel | sc-270583-V | r | Gene Silencing | Puromycin | 0 | ||
GSK3 beta siRNA (h) | sc-35527 | h | Gene Silencing | N/A | 62 | ||
GSK3 beta shRNA Plasmid (h) | sc-35527-SH | h | Gene Silencing | Puromycin | 62 | ||
GSK3 beta shRNA (h) Lentivirale Partikel | sc-35527-V | h | Gene Silencing | Puromycin | 62 | ||
GSK3 beta siRNA (m) | sc-35525 | m | Gene Silencing | N/A | 15 | ||
GSK3 beta shRNA Plasmid (m) | sc-35525-SH | m | Gene Silencing | Puromycin | 15 | ||
GSK3 beta shRNA (m) Lentivirale Partikel | sc-35525-V | m | Gene Silencing | Puromycin | 15 | ||
GSK3 beta siRNA (r) | sc-270460 | r | Gene Silencing | N/A | 7 | ||
GSK3 beta shRNA Plasmid (r) | sc-270460-SH | r | Gene Silencing | Puromycin | 7 | ||
GSK3 beta shRNA (r) Lentivirale Partikel | sc-270460-V | r | Gene Silencing | Puromycin | 7 |